Astellas Pharma ADR (ALPMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ALPMY | ONC | UTHR | ||
| Company | Astellas Pharma ADR | Beone Medicines Ltd | United Therapeutic | ||
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | ||
| Open | 15.0000 | 280.56 | 528.36 | ||
| High | 15.5400 | 283.94 | 533.73 | ||
| Low | 14.8300 | 279.71 | 524.30 | ||
| Latest | 14.9900 | 282.72 | 527.00 | ||
| Change | -0.0800 | +0.43 | -3.35 | ||
| % Change | -0.53% | +0.15% | -0.63% | ||
| Volume | 237,000 | 103,100 | 505,500 | ||
| 20-Day Average Volume | 164,945 | 299,170 | 607,470 | ||
| Previous Close | 15.0700 | 282.29 | 530.35 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 15.4196 | 310.79 | 512.01 | ||
| 20-Day Raw Stochastic | 26.13% | 3.24% | 74.28% | ||
| 20-Day Relative Strength | 48.98 | 34.81 | 56.94 | ||
| Weighted Alpha | +55.39 | +3.19 | +59.72 | ||
| Today's Opinion | 56% Buy | 40% Sell | 100% Buy | ||
| Previous Opinion | 72% Buy | 24% Sell | 100% Buy | ||
| Last Month's Opinion | 100% Buy | 88% Buy | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.49% since 03/12/26 | -0.90% since 03/12/26 | -1.09% since 03/12/26 | ||
| Low | 14.3815 on 03/16/26 | 279.71 on 03/19/26 | 523.50 on 03/18/26 | ||
| High | 15.8700 on 03/18/26 | 293.11 on 03/16/26 | 543.37 on 03/13/26 | ||
| 1-Month | |||||
| %Chg | -7.41% since 02/19/26 | -20.24% since 02/19/26 | +9.67% since 02/19/26 | ||
| Low | 14.3815 on 03/16/26 | 279.71 on 03/19/26 | 466.00 on 02/23/26 | ||
| High | 16.7100 on 02/24/26 | 372.73 on 02/24/26 | 548.12 on 03/10/26 | ||
| 3-Month | |||||
| %Chg | +11.45% since 12/19/25 | -10.55% since 12/19/25 | +1.91% since 12/19/25 | ||
| Low | 12.8500 on 12/22/25 | 279.71 on 03/19/26 | 455.63 on 01/20/26 | ||
| High | 16.9500 on 02/10/26 | 372.73 on 02/24/26 | 548.12 on 03/10/26 | ||
| 6-Month | |||||
| %Chg | +33.36% since 09/19/25 | -15.45% since 09/19/25 | +26.21% since 09/19/25 | ||
| Low | 10.0300 on 10/14/25 | 279.71 on 03/19/26 | 409.07 on 10/28/25 | ||
| High | 16.9500 on 02/10/26 | 385.22 on 11/17/25 | 548.12 on 03/10/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 27,271,576 | 30,956,770 | 23,244,176 | ||
| Shares Outstanding, K | 1,809,660 | 109,663 | 43,828 | ||
| Annual Sales | 12,621,330,000 | 5,343,030,000 | 3,182,700,000 | ||
| Annual Net Income | 334,930,000 | 286,930,000 | 1,334,700,000 | ||
| Last Quarter Sales | 3,708,270,000 | 1,498,170,000 | 790,200,000 | ||
| Last Quarter Net Income | 651,300,000 | 66,500,000 | 364,300,000 | ||
| 60-Month Beta | 0.15 | 0.53 | 0.84 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.44 on 02/04/26 | 0.58 on 02/26/26 | 7.70 on 02/25/26 | ||
| Latest Earnings Date | 04/24/26 | 05/06/26 | 04/29/26 | ||
| Most Recent Dividend | 0.170 on 09/26/25 | N/A | N/A | ||
| Next Ex-Dividends Date | 09/26/25 | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 10.74 | 77.03 | 19.36 | ||